Literature DB >> 10230623

Synthesis of dihydroxanthone derivatives and evaluation of their inhibitory activity against acetylcholinesterase: unique structural analogs of tacrine based on the BCD-ring of arisugacin.

S J Degen1, K L Mueller, H C Shen, J A Mulder, G M Golding, L L Wei, C A Zificsak, A Neeno-Eckwall, R P Hsung.   

Abstract

A general approach to synthesis of dihydroxanthone derivatives is described here. In vitro evaluation of these dihydroxanthones demonstrated that some derivatives possess moderate anti-cholinesterase activities and better selectivities than tacrine for acetylcholinesterase over butyrylcholinesterase. Structural effects on anti-cholinesterase activities were also examined, and docking experiments were carried out to provide preliminary understandings of these experimental observations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230623     DOI: 10.1016/s0960-894x(99)00115-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.

Authors:  Ziyad F Al-Rashid; Richard P Hsung
Journal:  Bioorg Med Chem Lett       Date:  2015-06-27       Impact factor: 2.823

2.  Effects per se of organic solvents in the cerebral acetylcholinesterase of rats.

Authors:  Adriana D C Obregon; Maria R C Schetinger; Maísa M Correa; Vera M Morsch; José E P da Silva; Marcos A P Martins; Hélio G Bonacorso; Nilo Zanatta
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

3.  (+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.

Authors:  Ziyad F Al-Rashid; Richard P Hsung
Journal:  Bioorg Med Chem Lett       Date:  2010-12-16       Impact factor: 2.823

4.  Territrem and butyrolactone derivatives from a marine-derived fungus Aspergillus terreus.

Authors:  Xu-Hua Nong; Yi-Fei Wang; Xiao-Yong Zhang; Mu-Ping Zhou; Xin-Ya Xu; Shu-Hua Qi
Journal:  Mar Drugs       Date:  2014-12-17       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.